Hearing the light

Why hear the light?

According to a report of the WHO, approximately 360 million people – 5% of the world’s population – suffer from disabling hearing impairment. When conventional hearing aids can no longer provide relief, auditory signals can be directly converted into neural impulses in the auditory nerve by cochlear implants, bypassing the impaired sound coding inside the cochlea. This "sensory prosthesis", which has already been developed in the 70s of the 20th century, is used by more than 500,000 hearing impaired patients and is considered the most succesful neuroprosthesis in the world. It uses a microphone to record sound and converts it in real time into electronic signals, splitting it into several channels coding for different frequency ranges. The information about the sound intensity in each frequency channel is then relayed to the auditory neurons via 12 to 24 electrode contacts placed along the tonotopic axis of the cochlea. Cochlear implants enable open speech comprehension in most users. However, they suffer from poor quality of sound encoding since, due to the large lateral spread of electrical current from each of the electrode contacts, too many auditory neurons surrounding the contact are stimulated at the same time (Fig. 1). Thus, the number of independent channels is very low (typically below 10) and the discrimination of frequency and volume is rather limited when listening with cochlear implants, as compared to normal hearing.

Figure 1: Schematic illustration of the function of cochlear implants
Top: Current electrical implant inside the cochlea with large lateral spread of electric stimulation from each of the 12 electrode contacts.
Bottom: Future optical implant with numerous emitters, whose light is focused onto the auditory nerve.


Since light can be much more efficiently focused, this fundamental problem could be solved by using light instead of electrical current to stimulate the neurons. Every light source would then excite a considerably smaller group of cells as compared to "electrical hearing" (Fig. 1). When sound stimuli are electronically split up into discrete frequency bands, future cochlear implants can then transfer this information via up to 100 independent stimulation channels using microscale light sources. This promises a significant improvement in the potential for discrimination of pitch and volume and thus a breakthrough in the restoration of hearing for the severely hearing impaired.


How can neurons hear the light?

Neurons are typically not light sensitive. However, Ernst Bamberg and Georg Nagel of the Max Planck Institute of Biophysics, along with Peter Hegemann of the Humboldt University in Berlin, have isolated and characterized a type of light sensitive proteins from green algae which has been tagged "channelrhodopsin". When using e.g. viruses as "gene shuttles" to transfer the genes coding for these proteins into different cells, they can be used as light-controlled "switches" to activate them, a procedure that has been termed "optogenetics". Specific viruses, which have been rendered harmless to the targeted organism by molecular modifications, are currently used within clinical studies for the treatment of congenintal blindness. We can use such viruses to introduce the optogenetic "switches" into auditory neurons to render them light sensitive. We have already demonstrated the feasibility of cochlear optogenetics in a first study with rodents. With initially single-channel stimulation we could activate the auditory system even in deaf animals, as we could demonstrate by recording light-evoked auditory brainstem responses. Additionally, we could show that, indeed, a more confined population of auditory neurons is activated when using light instead of electrical current as activating stimulus.


Where do we go from here?

This method will now need to be further developed to achieve the final goal of a clinical application. In cooperation with optogeneticists, we will develop channelrhodopsins that are suitable for use in the inner ear and allow stimulation of neurons as close to physiological conditions as possible using low light intensities. Funded by the European Research Council as the Advanced Grant "OptoHear", the Institute for Auditory Neuroscience in Göttingen is now developing efficient and safe means of gene transfer into animal auditory neurons with the goal of future clinical studies in profoundly deaf patients. Within the BMBF-funded project "Optical_CI" we are developing innovative flexible micro-LED cochlear implants to enable optical stimulation with 100 channels even within the inner ear of small rodents. The final goal ist to develop cochlear implants for human use with 100 micro-LEDs. These probes will then need to be hermetically sealed and their insertion, function, and stability will need to be tested in first animal trials. In functional studies we will then measure the temporal-, frequency-, and intensity-resolution of sound coding with optical multi channel implants and compare this to normal and "electrical" hearing. In collaboration with Göttingen x-ray scientist Tim Salditt and colleagues we will then analyze the position and orientation of the optical cochlear implants and their light emitters within the cochlea using high resolution x-ray tomography (Fig. 2). Further, we will need to perform microscopic examiniations of inner ear and brain tissue to analyze potential damage by the gene shuttles, exogenous proteins, and optical stimulations.

Figure 2: Optical cochleae implant in a rat cochlea
Reconstruction of the cochlea of a rat based on x-ray phase contrast tomoraphy. An about 300 µm wide encapsulated micro-LED implant (blue) has been inserted into the scala tympani (tympanic duct) of the cochlea (grey) of a rat. (insertion depth ca. 0.75 turns). The green structure indicates the basilar membrane with the sensory organ of Corti, which could not be reconstructed over its entire length.